EPG Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
EPG Wealth Management's GILD Position: Q2 2026 in Review
EPG Wealth Management reduced its Gilead Sciences (GILD) stake by 6% in Q2 2026, selling an estimated $34.1K and leaving 4,023 shares worth $508K. The position accounts for 0.12% of the portfolio, ranked #144.
EPG Wealth Management first reported a position in GILD in Q4 2019 and has held it in 15 quarters since. The position peaked at $977K in Q1 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- EPG Wealth Management held 4,023 shares of Gilead Sciences worth $508K as of Q2 2026.
- EPG Wealth Management sold 259 Gilead Sciences shares in Q2 2026, an estimated $34.1K.
- Gilead Sciences made up 0.12% of EPG Wealth Management's portfolio in Q2 2026, its #144 holding.
- EPG Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 15 quarters since.
- EPG Wealth Management's Gilead Sciences position peaked at $977K in Q1 2023.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on EPG Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.